Phase I Open-label, First-in-human Study to Evaluate Feasibility and Safety of Tissue Engineered Veins in Patients With Chronic Venous Insufficiency.
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: VERIGRAFT IBERIA, SL
- Phase: I
- Execution start: 09/09/2021
- End of execution: 30/12/2023
- IP: JOSE PATRICIO LINARES PALOMINO